14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026
DRSK vs ADME: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 16, 2026, Aptus Behavioral Momentum ETF (ADME) is the stronger overall head-to-head candidate over Aptus Defined Risk ETF (DRSK) in the Tradestie Institutional Equity Comparison Engine, winning 2–1 core matrix metrics and 0–0 across our 6-pillar institutional scorecard (led by composite factor balance). DRSK carries a Unified Composite Score of 43.7/100 (HOLD) at $26.96 (N/M Forward P/E, N/A operating margin), whereas ADME carries 61.3/100 (BUY) at $54.57 (N/M Forward P/E, N/A operating margin).
Technical & Structure Timing Caution: DRSK is currently in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 36.4); meanwhile ADME is in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 40.0). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on DRSK vs ADME. Trailing 12-month operating profitability (DRSK N/A vs ADME N/A) and valuation multiples (DRSK N/M vs ADME N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Institutional Equity value chain with N/A market capitalization and N/A operating margin.
OpEx & R&D ReinvestmentN/A
90D Engineering Disclosures0 Published
Investor FAQ DRSK vs ADME Key Questions & Quantitative Answers
As of Nov 16, 2026, Aptus Behavioral Momentum ETF (ADME) is the stronger overall head-to-head candidate over Aptus Defined Risk ETF (DRSK) in the Tradestie Institutional Equity Comparison Engine, winning 2–1 core matrix metrics and 0–0 across our 6-pillar institutional scorecard (led by composite factor balance). DRSK carries a Unified Composite Score of 43.7/100 (HOLD) at $26.96 (N/M Forward P/E, N/A operating margin), whereas ADME carries 61.3/100 (BUY) at $54.57 (N/M Forward P/E, N/A operating margin). Technical & Structure Timing Caution: DRSK is currently in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 36.4); meanwhile ADME is in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 40.0). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
DRSK and ADME split Growth & Scale metrics: DRSK posts N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin), compared with ADME at N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin). On trailing 12-month operating scale, DRSK generates N/A in USD-normalized revenue versus N/A for ADME. In operating R&D and SG&A reinvestment, DRSK deploys N/A (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for ADME.
DRSK and ADME trade at balanced relative valuation multiples. DRSK trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin), whereas ADME trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against DRSK (N/A ROE) versus ADME (N/A ROE) capital efficiency.
In options market volatility and institutional positioning, DRSK carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.32β · 5% Vol realized risk). By comparison, ADME carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.83β · 15% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.